Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SPOKE WITH FINRA
And asked about Reverse Split.That guy said, a company can have as many reverse splits as possible with approval from Finra.There is no limitation, those who are approved for any splits come up on daily list on Finra.
So IMHO, GMBS reverse split is imminent.Sold my position after spoke with Finra today.
Quote:"Following SeD Biomedical's preliminary due diligence, SeD Biomedical has informed Amarantus' management of strategic measures that must be met by creditors and certain other parties as a condition for any investment, loan or asset injection by SeD Biomedical."
Apparently they found what they could.Did they know that GC was advisor to Intl infusion at the same time?.
Dont have faith in the PR's released by these crooks.They succeeded very well by failing and cheating shareholders.They released several PRs last year about CGMP compliance,ESS ,RPDD applications., infamous tweets by that irresponsible CEO..dont believe them at all.
How come 8-k had the ex CFO name, did n't he leave the company?
They all working hand in hand with Avant as well, this guy is trying to move to AVAnt.SeD should completely ceo and his corrupt gang from this company.He had all bad ties who can do very bad things for shareholders.
GREAT READ.THANK YOU.
Quidel Corporation - In May of 2013, Quidel Corporation, a competitor of ours,
purchased BioHelix.
From 10-K
Quidel is a good start to analyze what this company is worth.
Another FDA approval pretty soon
Company expected 2 approvals in first half, they received one on 3/31 and the second one can happen pretty soon IMHO.
This is a buyout play IMHO.
Not many companies with this many FDA approvals in MDx space.
ON OR BEFORE LEGAL?
Or is it ON OR AFTER legal?
ON OR BEFORE does give the company any day before or on that day they can reverse split, so they dont have any fiduciary responsibility to inform the shareholders before they do a reverse split?.
I guess its ripe for M&A, AJMHO.
RE:So the FDA approvals don't mean anything to you??
Good question.Not one approval, it has 5 and one more in the pipeline expected in the first half of 2017, about to happen pretty soon.
Its a value based company.Toxics brought it down to subpennies,imho.I was burned last year.
Potential target to get bought in MDx space.
FROM 10-K
In November 2012, we launched our first FDA-cleared test for C. diff, a bacteria that causes life-threatening gastrointestinal distress in hospital patients. In addition to our C. diff assay, we have three additional FDA-cleared tests, Group B Strep assay for which we received FDA clearance in April 2015 and launched commercially in June 2015, Shiga toxin producing E. coli assay, or STEC, for which we received FDA clearance in March 2016 and launched commercially in August 2016, and Staph ID/R (“SIDR”) assay for which we received FDA clearance in March of 2016 and commercially launched on September 30, 2016. Additionally, we have completed clinical trials and submitted 510(k) applications to the FDA for two assays—a food borne pathogens panel and a test for Bordatella pertussis (whooping cough). We expect a decision from the FDA on these two applications during the first half of 2017. We also have three other assays in various stages of product development: (i) a test for Chlamydia-Gonorrhea, (ii) a pre-surgical nasal screen for Staphylococcus aureus, and (iii) a panel for Candida blood infections.
Main difference in VALUE of GBSN when it was $7 and now?
Additional approval of FDA and company is expecting one more soon.
The company should be a target for aquisition IMHO.
The value in this company is improved from when it was trading at 6-7 range and now.
IMHO.
Bordetella Direct Test Receives FDA Clearance
http://gbscience.com/bordetella-direct-test-receives-fda-clearance/
Why this was not picked up by media outlets?
“Guarantor” means each Restricted Subsidiary that provides a Note Guarantee; provided that upon release or discharge of any Guarantor from its Note Guarantee in accordance with this Agreement, such Restricted Subsidiary ceases to be a Guarantor.
May be held at LAMCO, never know.Too many connections between Lehman and WMI, A&M,Weil,BOD.
So he knew Lympro was a good product and transferred it to Avant and he himself got a position as a director of Avant?.Wow.Speechless.
No.Its is held with LBHI plant trust.Upon resolving all issues it gets distributed among creditors and shareholders who were not satisfied fully with cash, as per the waterfall and plan,IMHO.
My guess is, LAMCO shares might be issued and distributed.
Is it legal to distribute assets to another company and joining that company as a director with shareholders consent?.Distributing assets to note holders with out seeking shareholders vote?.
So all assets are given to other companies and leave nothing but a shell for shareholders?.
How come that CFO is still in the 8-K?.These crooks are still working hand in hand.Time to go for a class action IMHO.
Seriously, What is the ticker?.Thanks.
DEGENRATIVE DISK - Kristin Comella's recent publication
"Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease"
http://translational-medicine.biomedcentral.com/articles/10.1186/s12967-016-1109-0
Adipose Cells for Degenerative Disc Disease Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT02097862?term=bioheart&rank=6
Gold mine, IMHO.
No.But it was created for the benefit of equity holders and to utilize the NOLs.
LEH: Equity was extinguished - not true.They were given escrows too.And substituted with one liquidating trust stock.
WHY USRM RAT GETS APPROVAL?
IMHO.
100 Million is put into research
Extensive research done on MARVEL
10 yrs spent on PART - I & PART - 2
PART - I had great results.
Check this here
"Bioheart Inc. Announces Positive Results in the MARVEL Phase II/III Clinical Trial"
http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=195615
Who is writing to Judge?
So you think they are such a bunch of idiots to hire a valuation firm to value (only) certain assets and they dont know whether they could distribute less or more or milk the estate?.
Reality is WMI HAD $33B(approximately) in assets and less than $8B in liabilities.
JPM did not purchase anything of WMI assets from FDIC.Dont know whether they purchased anything from WMI directly though.
ONLY certain assets were valued and based on those values, we see nothing available,imho.
Once they start valuing, lol ,they got to pay up imho for sure.
"PURSUANT TO P&A IS STRONG", imho out of P&A it looks nothing, within P&A, BOOKVALUE +INTERESTS+LIABILITIES...etc, AJMHO.
WMILT 10-K Subordinated claims will be paid prior to any distribution to former holders of equity interests in WMI.
Trust Beneficiaries who were projected to receive value on account of their Allowed Claims against the Debtors have been issued LTIs evidencing their right to receive distributions from the Trust if, and to the extent, sufficient cash is available with respect thereto. If and when distributions from the Trust become available to Trust Beneficiaries who have not received LTIs to date, additional LTIs will be issued to such Trust Beneficiaries in accordance with the Plan and the distribution priorities that are summarized in Annex C of the Trust Agreement.
Pursuant to the Plan, holders of claims in Class 18 (“Subordinated Claims”) will receive distributions before the holders of claims in Classes 19, 21 and 22 (the former holders of equity interests in WMI (“Equity Interests”)). As of December 31, 2016, outstanding allowed Subordinated Claims totaled $38.2 million. In addition, during the Debtor’s bankruptcy proceedings, the Bankruptcy Court ordered that certain Class 17B claims (defined in the Plan as WMB Subordinated Notes Claims) be subordinated to the level of Class 18.
Such Class 17B claims remain disputed and unliquidated. The allowance of any Subordinated Claims (including WMB Subordinated Notes Claims) would affect the amount, if any, of distributions that would otherwise be available to the former holders of Equity Interests. For additional information regarding these matters, see Item 3 of this Form 10-K under “WMB Subordinated Debt Misrepresentation Claims.”
Furthermore, and as discussed in more detail in Item 3 of this Form 10-K under “Mortgage Pass-Through Litigation”, the Bankruptcy Court has indicated that it will allow one Claimant to re-file its proof of claim as either a General Unsecured Claim (as defined in the Plan) or a Subordinated Claim, as determined by the Court, when recoveries become available to holders of Subordinated Claims. Such re-filing, and the ultimate resolution of any such claim may affect the amount, if any, of distributions that would otherwise be available to former holders of Equity Interests.
That lier should be in jail for all the fraud he committed and for damaging shareholder lives.Sed should throw this guy away.
FDA - KRISTIN COMELLA TRANSCRIPT
https://google2.fda.gov/search?q=%22U.S.%20Stem%20Cell,%20Inc%22&client=FDAgov&proxystylesheet=FDAgov&output=xml_no_dtd&site=FDAgov&requiredfields=-archive:Yes&sort=date:D:L:d1&filter=1
DR. WITTEN: Our next speaker represents
U.S. Stem Cell Inc.
DR. COMELLA: Thank you. I'm Kristin
Comella. I'm the chief science officer of U.S.
Stem Cell. We are a publicly traded company, so I
must remind you of the forward-looking statements.
We have a comprehensive mix of products. We've
been a company since 1999, and our focus has
always been to bring stem cell therapies to
patients.
I think this quote is particularly
important today. All truth passes through three
stages. First, it's ridiculed. Second, it's
violently opposed. And third, is it accepted as
being self-evident?
The re-implantation of autologous HCT/Ps
is recognized in the regulations and during the
same surgical procedure, this is considered the
practice of medicine. And there are a variety of
82
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
different things that are recognized under this,
including fat grafts, skin graft, bone marrow
transplants, platelet rich plasma, tendon and
ligament grafts, vascular grafts, hair grafts, and
bone grafts. All of these procedures are
considered surgical and they did not go through
double-blind, placebo-controlled trials.
I want to focus on the comparison
between bone marrow and fat tissue, and, in
particular, something called stromal vascular
fraction that a lot of people have been discussing
today. The reason that bone marrow is accepted
under a 510K is because there was preexisting
technology to the 1976 amendments covering medical
devices. Fat tissue does not have that same
luxury because there was no preexisting
technology. But why would fat and bone marrow be
viewed separately? When you're taking cells from
bone marrow, why is this different than taking
cells from fat? And in particular, fat is a less
invasive method of collecting and also isolating
the cells with lower risks associated with it.
83
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
In addition, there are higher numbers of
cells and stem cells and lower numbers of white
blood cells which are inflammation creating in the
fat tissue versus the bone marrow. So
scientifically speaking, it makes zero sense that
we'd regulate these two tissues in a different
manner. Why would the FDA regulate our own body
tissue and consider this a drug?
Who is responsible for paying for these
trials if the FDA doesn't do it? Pharmaceutical
companies typically cover the expenses associated
with doing a double-blind, placebo-controlled
trial. Because there is no drug to sell at the
end of this because it's cells from your own body,
no pharmaceutical company is going to cover these
trials, so who is going to cover these trials if
they're going to be mandated by the FDA?
In addition, why would the FDA regulate
cells from bone marrow and fat tissue different?
These are some images from our clinic where we
treat patients. These are our medical
practitioners who care very much about their
84
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
patients, and their safety and outcomes, and who
have become, in some sense, disgusted with the
medical system and some of the products that are
currently available that are not making patients
better. We need new options for patients.
The process is very simple. It can be
done in under 60 minutes. A small sample of fat
tissue is taken in a minimally manipulated process
where the patient remains awake. There is no
general anesthesia. The cells are obtained and
can be administered back to that same patient.
We've trained over 600 practitioners
throughout the world and in the U.S. who are doing
these procedures safely. We have over 6,000 cases
documented and when you consider some of our
colleagues, there are tens of thousands of cases
documented. If this was really a safety concern,
there would be more than a handful of adverse
events which are being reported. And that's all
we have right now, just a handful out of ten
thousands of patients. And there is no drug on
the planet that has that kind of record.
85
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
Regenerative medicine is here to stay
and it's continuously growing. We, as a field,
have an obligation to bring these therapies
forward. Patients have a right to make an
informed consent decision about how they're going
to use these treatments on themselves. They have
a right to alternative therapies. We need more
funding for these patient trials and the
government should not regulate all bodies. I'm
Kristin Comella and I will always stand up for
patient rights. Thank you. (Applause)
FDA INVITED USRM FOR GUIDANCE ON HUMAN CELLS&TISSUES
Final Agenda: Part 15 Hearing: Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products
https://www.fda.gov/biologicsbloodvaccines/newsevents/workshopsmeetingsconferences/ucm509279.htm
So in FDA's opinion USRM has a fighting chance, IMHO.
KRISTIN COMELLA PRESENTATION - INTO PARKINSON's TOO
Regenerative Medicine: The Future of Medicine is Here
by: Kristin Comella, CSO, US Stem Cell Clinic 12-Dec-2016
http://www.bioleaders-forum.com/content-pieces/regenerative-medicine-the-future-of-medicine-is-here
MIT & HARVARD WILLIAM P.MURPHY
Son of a former nobel prize winner.
Liquidating Trust Interests(LTIs) or cash or WMIH shares or a combination of either two or all, IMHO.
Yes Sir.Here is the quote.
"And i think that recovery is meaningful.Its not the typical WARRANT with a strike price of a zillion dollars, its not a sub,sub,subordinated interest in a liquidation project"
May be she meant LTI's.No warrants in our case as per Edgar Sargent in the court on final confirmation day.But the question is, she is under the impression that shareholders already RECEIVED shares + something, but in reality only shares.Time to write the judge.The liquidating trust is fooling shareholders and very irresponsible in providing proper information regarding LTIs.
Those who are good with dealing courts please step up and stand for all shareholders.Nate Thoma made our case, not these high paying lawyers.
Did you get it, yet?
You can write up a letter with some of the points i mentioned earlier.If you need any information, please post it here so that we all can help for the correct information.Once the letter is finalized, it can be shared here, all other former shareholders can write to the court asking for the right information.
MARVEL Phase II/III Clinical Trial
MUST READ
http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=195615
IMHO every former shareholder should write a letter to THJMW asking what was distributed to former shareholders in $ value.
If Warrants were issued and received by shareholders as mentioned to Congress, why did we not receive it.
Why is Liquidating Trust releasing statement like 'if and if any' for issuing LTIs when the tranches were valued by Valuation Research, even after 5 yrs after the Effective date?.
What happened to the warrants and what they are worth?
What assets are with LT and what assets are transferred to WMIH?.
IS THE ESTATE NOT TELLING THE TRUTH TO ITS SHAREHOLDERS?
When did the shareholders RECEIVED shares and WARRANTS?
Time to write a letter to congress.
"shareholders received stock and warrants in a subsidiary that was capitalized
with $150 million in new money."
Where is the warrants?.Who is lying?.Is the estate not revealing what is issued to shareholders?.
We should all write a letter to THJMW.
Thanks for posting the document NDT.
INSIDER HOLDINGS OF USRM - STICK IT UP PLEASE
INSANE
https://www.sec.gov/cgi-bin/own-disp?action=getissuer&CIK=0001388319
TOMAS MIKE
https://www.sec.gov/cgi-bin/own-disp?action=getowner&CIK=0001388662
Comella Kristin C
https://www.sec.gov/cgi-bin/own-disp?action=getowner&CIK=0001465760
MURPHY WILLIAM P JR
https://www.sec.gov/cgi-bin/own-disp?action=getowner&CIK=0001388479
MIT Lifetime Achievement Award Winner William P. Murphy, Jr
Nice intro about him
They got a bank with $40B equity as per sec filings.
Does thievery has statute of limitation?